OncoMed Pharmaceuticals, Inc. EBITDA Margin 2013-2018 | OMED
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for OncoMed Pharmaceuticals, Inc. (OMED) over the last 10 years. The current EBITDA margin for OncoMed Pharmaceuticals, Inc. as of December 31, 2018 is .
| EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2018-12-31 | $0.05B | $-0.01B | -20.00% |
| 2018-09-30 | $0.06B | $0.01B | 8.93% |
| 2018-06-30 | $0.04B | $-0.01B | -29.27% |
| 2018-03-31 | $0.04B | $-0.02B | -57.50% |
| 2017-12-31 | $0.04B | $-0.04B | -102.63% |
| 2017-09-30 | $0.02B | $-0.07B | -304.35% |
| 2017-06-30 | $0.02B | $-0.08B | -350.00% |
| 2017-03-31 | $0.03B | $-0.10B | -384.00% |
| 2016-12-31 | $0.03B | $-0.10B | -404.00% |
| 2016-09-30 | $0.03B | $-0.10B | -396.15% |
| 2016-06-30 | $0.03B | $-0.10B | -408.00% |
| 2016-03-31 | $0.02B | $-0.10B | -417.39% |
| 2015-12-31 | $0.03B | $-0.08B | -307.41% |
| 2015-09-30 | $0.03B | $-0.07B | -255.17% |
| 2015-06-30 | $0.04B | $-0.06B | -127.91% |
| 2015-03-31 | $0.04B | $-0.05B | -111.36% |
| 2014-12-31 | $0.04B | $-0.05B | -122.50% |
| 2014-09-30 | $0.05B | $-0.04B | -72.00% |
| 2014-06-30 | $0.04B | $-0.03B | -77.27% |
| 2014-03-31 | $0.04B | $-0.03B | -68.29% |
| 2013-12-31 | $0.04B | $-0.02B | -57.89% |
| 2013-09-30 | $0.03B | $-0.02B | -85.19% |
| 2013-06-30 | $0.02B | $-0.02B | -114.29% |
